Tasigna 200 mg
Tasigna 200 mg is a medicine authorised by Swissmedic under authorisation number 58007. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 24 July 2007 and the authorisation is valid without a time limit. ATC code L01EA03 places the medicine in the group Antineoplastic agents.
| Authorisation number | 58007 |
|---|---|
| Name | Tasigna 200 mg |
| Full name | Tasigna 200 mg, Kapseln |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EA03 |
| First authorisation | 24 July 2007 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Tasigna 200 mg, Kapseln | A | 24 July 2007 |
| 2 | Tasigna 150 mg, Kapseln | A | 24 August 2010 |
| 3 | Tasigna 50 mg, Kapseln | A | 31 January 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Kapsel(n) | L01EA03 | 07.16.1. | A |
| 2 | 112 | Kapsel(n) | L01EA03 | 07.16.1. | A |
| 4 | 112 | Kapsel(n) | L01EA03 | 07.16.1. | A |
| 5 | 120 | Kapsel(n) | L01EA03 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Tasigna 200 mg authorised in Switzerland?
Yes. Tasigna 200 mg is authorised by Swissmedic under authorisation number 58007, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Tasigna 200 mg have?
Tasigna 200 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Tasigna 200 mg?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.